From Divestiture to IPO: How Manus's Revenue Growth Changes Who Controls the Exit

When China’s NDRC issued its divestiture order in June 2026, the transaction looked like a
forced unwinding, a regulatory authority reclaiming jurisdiction over Chinese-origin
intellectual property that had migrated into a US parent. The
original June 14 brief on the divestiture order framed it as a clear assertion of
Beijing’s reach over Singapore-headquartered, Chinese-origin AI companies. That framing
was accurate. It’s also incomplete now.

A forced divestiture at a fixed price is straightforward. What’s less straightforward is
a forced divestiture where the asset may have appreciated by 4x to 5x during the separation
process, and where the original backers need to raise $1 billion in outside capital to
execute the repurchase. That capital raise is a market event. It introduces new investors
with their own pricing requirements, due diligence expectations, and exit horizons. And it
changes who has leverage over the ultimate structure of the Manus exit.

Section 1: The Revenue Story

Manus reported $100M in annualized recurring revenue at the time of its acquisition by
Meta, confirmed by the Wall Street Journal. Multiple investor-sourced reports now
place that figure at $400M to $500M ARR. The $400-500M figure hasn’t been confirmed by a T1
or T2 primary source, it circulates through arr.club, Dealroom, and The Information’s
headline coverage, all investor-facing outlets with access to founder and backer
conversations. The consistency across three independent outlets makes the directional claim
credible enough to analyze. But it remains qualified.

Take it at face value and the math is stark. A $2 billion repurchase price on $400M–$500M
ARR implies a 4x–5x revenue multiple. At the time of the original acquisition, Meta paid
roughly 20x ARR on the $100M figure. The multiple compression alone represents a significant
revaluation, and a meaningful discount for the original backers executing the repurchase,
assuming the revenue figure holds in formal due diligence.

That’s the first leverage point. If Manus’s revenue growth is real and documentable, the
original backers are acquiring a materially more valuable business at a price set when it was
worth far less. The $2B repurchase price may have been negotiated before the full revenue
trajectory was clear. Whether Meta’s transaction team or the NDRC order’s timing reflects
awareness of the growth curve is unclear. What’s clear is that the spread between the $2B
price and a 4x–5x ARR multiple at current revenue represents significant economic value –
and outside investors pricing the $1B raise will be looking at that spread when they decide
whether to participate.

Section 2: The Regulatory Leverage Question

The intuitive read on Beijing’s divestiture order is that it gives China more control over
Manus. That’s partially right. The NDRC order forced operational separation, confirmed by
Simply
Wall St’s coverage and Bloomberg cross-reference reporting, Meta has halted data sharing
and system access. Chinese-origin IP is back under structures the NDRC can influence directly. In that narrow sense, Beijing got what it ordered.

But the revenue growth complicates the leverage calculation. A Manus worth $400M–$500M
ARR, if that figure survives a data room, is an asset with enough commercial credibility
to attract institutional capital on its own terms. The $1B raise reportedly being explored
by the original backers isn’t a backstop. It’s a signal that external investors are being
asked to price the asset independently of the NDRC order’s mechanics. Those investors will
have expectations: a credible path to liquidity, transparent governance, and a cap table
structure that doesn’t expose them to future regulatory intervention of the same kind.

The HK IPO pathway, reported across multiple outlets citing Bloomberg, addresses exactly
those expectations. A Hong Kong listing provides a regulated public market exit, operates
within a framework that Beijing can observe and influence without directly controlling, and
gives institutional investors the liquidity mechanism they need. The China JV structure
that reportedly precedes the listing creates the ownership architecture that satisfies the
NDRC’s underlying concern, Chinese-origin IP in Chinese-controlled hands.

The question is whether Beijing wants the HK IPO pathway to succeed on commercial terms,
or whether the divestiture order was primarily about reasserting jurisdictional control
regardless of what happens to the asset’s commercial trajectory afterward. Those are two
different regulatory objectives. The first is compatible with a well-financed relisting that
creates a flagship Chinese AI public company. The second might accept a lower-value outcome
if it establishes the precedent that Chinese-origin AI IP is subject to NDRC jurisdiction
wherever it migrates.

The $1B raise will reveal which objective is operative. If Beijing facilitates the
raise, through state-adjacent capital or by signaling regulatory comfort to potential
investors, the commercial outcome is the priority. If the raise faces bureaucratic friction
or if the JV structure requires terms that discourage outside capital, the precedent-setting
objective takes priority over the commercial one.

Section 3: The Two Pathways and What Each Signals

The China JV structure and the HK IPO aren’t alternatives. They’re sequential. The JV
comes first, it’s the ownership restructuring that brings Manus back under Chinese
corporate control. The HK IPO is the destination, assuming the JV structure is established
and the $1B raise closes. Neither step is confirmed. Simply Wall St uses “may” throughout
its JV and listing coverage, and no formal filing or regulatory approval has been
reported.

If the JV structure forms and the raise closes, two things follow. First, the HK IPO
pathway becomes a formal planning exercise with a timeline that’s probably 12–18 months out
from the JV formation date, given HKEX listing requirements and the due diligence cycle for
a company of this size. Second, Manus becomes the first reported case of a Beijing-driven AI
asset divestiture that completed the full cycle: NDRC order → operational separation → JV
restructuring → public market exit. That precedent matters for every cross-border AI M&A
deal involving Chinese-origin IP. The June 21 cross-border due diligence
brief established the framework risk; a completed Manus cycle would confirm it with a
data point.

If the JV structure doesn’t form, or forms but the raise stalls, Manus is in a more
ambiguous position. Operational separation is complete. The company is no longer inside
Meta. But without a clear ownership structure and outside capital, the relisting pathway
collapses back into a bilateral negotiation between the original backers and whatever terms
they can sustain without institutional support. At $400-500M ARR, the company doesn’t
need outside capital to operate. But the original backers can’t fund a $2B repurchase from
operating cash flow on that ARR base. The raise is load-bearing.

The real story is that the NDRC order may have created an asset that’s now
too commercially valuable to exit quietly. A Manus that’s growing 4x–5x doesn’t disappear
into a private restructuring. It becomes a market event, one that institutional investors,
Hong Kong regulators, and Beijing’s own capital markets priorities all have a stake in
shaping. Whether that outcome strengthens Beijing’s leverage or creates obligations Beijing
didn’t plan for is the open question. Watch the $1B raise process in Q3 2026. The terms
on which it closes, or doesn’t, will answer it.